Common Contracts

7 similar null contracts by Cellectar Biosciences, Inc., Silo Pharma, Inc., Know Labs, Inc., Worksport LTD

COMMON STOCK PURCHASE WARRANT KNOW LABS, INC.
Know Labs, Inc. • July 22nd, 2024 • Measuring & controlling devices, nec • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received by the Company, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on __________, 2029 (the “Termination Date”) but not thereafter, to purchase from Know Labs, Inc., a Nevada corporation (the “Company”), up to _____ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to recei

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.
Silo Pharma, Inc. • July 22nd, 2024 • Apparel & other finishd prods of fabrics & similar matl

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT C cellectar biosciences, inc.
Cellectar Biosciences, Inc. • July 22nd, 2024 • Pharmaceutical preparations • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City Time) on the Termination Date but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided however, that, in lieu of Warrant Shares, such Holder may elect to receive pre-funded common stock purchase warrants in lieu of some or all Warrant Shares in the form set forth on Exhibit C hereto (the “Pre-Funded Warrants”), if at the time of exercise, the Holder or its Affiliates would beneficially own in excess of the Beneficial Ownership Limitation (as defined below), in which

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.
Silo Pharma, Inc. • July 22nd, 2024 • Apparel & other finishd prods of fabrics & similar matl

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 18, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of April 23, 2024.

FORM OF PREFUNDED WARRANT Worksport Ltd.
Worksport LTD • July 22nd, 2024 • Motor vehicle parts & accessories • New York

THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Worksport Ltd., a Nevada corporation (the “Company”), up to ___________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT B cellectar biosciences, inc.
Cellectar Biosciences, Inc. • July 22nd, 2024 • Pharmaceutical preparations • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City Time) on the Termination Date but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided however, that, in lieu of Warrant Shares, such Holder may elect to receive pre-funded common stock purchase warrants in lieu of some or all Warrant Shares in the form set forth on Exhibit C hereto (the “Pre-Funded Warrants”), if at the time of exercise, the Holder or its Affiliates would beneficially own in excess of the Beneficial Ownership Limitation (as defined below), in which

COMMON STOCK PURCHASE WARRANT A cellectar biosciences, inc.
Cellectar Biosciences, Inc. • July 22nd, 2024 • Pharmaceutical preparations • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City Time) on the Termination Date but not thereafter, to subscribe for and purchase from Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided however, that, in lieu of Warrant Shares, such Holder may elect to receive pre-funded common stock purchase warrants in lieu of some or all Warrant Shares in the form set forth on Exhibit C hereto (the “Pre-Funded Warrants”), if at the time of exercise, the Holder or its Affiliates would beneficially own in excess of the Beneficial Ownership Limitation (as defined below), in which

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!